Literature DB >> 9738042

Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women.

P A Jenum1, B Stray-Pedersen.   

Abstract

The development of specific antibodies following primary Toxoplasma gondii infection during pregnancy was assessed by six different antibody assays: dye test, Platelia Toxo-IgG, Toxo-Screen DA IgG, Platelia Toxo-IgM, Toxo-ISAGA IgM, and Platelia Toxo-IgA. A total of 126 sera from 27 pregnant women, for whom the time of acquisition of infection could be estimated fairly accurately, were included. All tests showed great individual variation in the peak amounts of antibodies detected. The times elapsed after infection until the peak was reached also varied greatly from individual to individual: the ranges were 2 to 21 weeks for the dye test, 4 to 36 weeks for Platelia Toxo-IgG, 4 to 30 weeks for Toxo-Screen DA IgG, 2 to 18 weeks for Platelia Toxo-IgM, 1 to 6 weeks for Toxo-ISAGA IgM, and 2 to 21 weeks for Platelia Toxo-IgA. In the early phase of the infection the dye test and the specific-IgM tests were the most sensitive. Toxo-Screen DA IgG was more sensitive than Platelia Toxo-IgG in the acute phase, while Platelia Toxo-IgA was clearly the least sensitive assay. Of the sera collected 21 to 52 weeks after infection, all were positive by the dye test, all except one (which was negative by Platelia Toxo-IgG) were positive by the specific-IgG tests, approximately 80% were positive by the IgM tests, and 45% were positive by the IgA test. Due to the great individual variation it seems impossible to estimate when the infection occurred based on results obtained from a single serum, and it may even be difficult to assess when a titer increase in paired sera is detectable unless the first sample is only marginally positive. As a diagnostic criterion a dye test titer of >/=300 IU/ml has a low sensitivity for recent primary infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9738042      PMCID: PMC105086     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  The relationship and significance of antibody titres as determined by various serological methods in glandular and ocular toxoplasmosis.

Authors:  K A Karim; G B Ludlam
Journal:  J Clin Pathol       Date:  1975-01       Impact factor: 3.411

Review 2.  Current status of toxoplasmosis in pregnancy in Norway.

Authors:  B Stray-Pedersen; P Jenum
Journal:  Scand J Infect Dis Suppl       Date:  1992

3.  IgA antibodies against P30 as markers of congenital and acute toxoplasmosis.

Authors:  A Decoster; F Darcy; A Caron; A Capron
Journal:  Lancet       Date:  1988-11-12       Impact factor: 79.321

4.  Duration of IgM antibodies to Toxoplasma gondii after acute acquired toxoplasmosis.

Authors:  Y Naot; D R Guptill; J S Remington
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226

5.  Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity.

Authors:  G Desmonts; J S Remington
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

6.  Platelia-Toxo IgA, a new kit for early diagnosis of congenital toxoplasmosis by detection of anti-P30 immunoglobulin A antibodies.

Authors:  A Decoster; B Slizewicz; J Simon; C Bazin; F Darcy; G Vittu; C Boulanger; Y Champeau; J L Demory; M Duhamel
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

7.  Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial.

Authors:  J McAuley; K M Boyer; D Patel; M Mets; C Swisher; N Roizen; C Wolters; L Stein; M Stein; W Schey
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

8.  Value of specific immunoglobulin A detection by two immunocapture assays in the diagnosis of toxoplasmosis.

Authors:  F Foudrinier; C Marx-Chemla; D Aubert; A Bonhomme; J M Pinon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-07       Impact factor: 3.267

9.  Screening programme for congenital toxoplasmosis in France.

Authors:  P Thulliez
Journal:  Scand J Infect Dis Suppl       Date:  1992

10.  Studies on the serodiagnosis of toxoplasmic lymphadenitis.

Authors:  J G Montoya; J S Remington
Journal:  Clin Infect Dis       Date:  1995-04       Impact factor: 9.079

View more
  14 in total

1.  European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index.

Authors:  Eskild Petersen; Maria Victoria Borobio; Edward Guy; Oliver Liesenfeld; Valeria Meroni; Anne Naessens; Emma Spranzi; Philippe Thulliez
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

2.  Evaluation of Toxoplasma gondii immunoglobulin G (IgG) and IgM assays incorporating the newVidia analyzer system.

Authors:  Adriana Calderaro; Giovanna Piccolo; Simona Peruzzi; Chiara Gorrini; Carlo Chezzi; Giuseppe Dettori
Journal:  Clin Vaccine Immunol       Date:  2008-05-14

3.  Seroreactivity to and avidity for recombinant antigens in toxoplasmosis.

Authors:  Klaus-Ingmar Pfrepper; Gisela Enders; Marion Gohl; Doris Krczal; Harald Hlobil; Doris Wassenberg; Erwin Soutschek
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

4.  Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay.

Authors:  D Aubert; G T Maine; I Villena; J C Hunt; L Howard; M Sheu; S Brojanac; L E Chovan; S F Nowlan; J M Pinon
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

5.  Comparisons of Toxoplasma gondii Prevalence in Rural and Urban Areas of Al-Najaf Province of Iraq Using Serological Methods.

Authors:  K Abdul Ameer Jaber; R Aamer Noori
Journal:  Arch Razi Inst       Date:  2021-12-30

6.  Toxoplasma gondii antibody profile in HIV-infected pregnant women and the risk of congenital toxoplasmosis.

Authors:  E G Lago; G S Conrado; C S Piccoli; R L Carvalho; A L Bender
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-15       Impact factor: 3.267

7.  LDBio-Toxo II immunoglobulin G Western blot confirmatory test for anti-toxoplasma antibody detection.

Authors:  Jacqueline Franck; Yves Jean-François Garin; Henri Dumon
Journal:  J Clin Microbiol       Date:  2008-05-14       Impact factor: 5.948

8.  Development and clinical evaluation of a rapid serodiagnostic test for toxoplasmosis of cats using recombinant SAG1 antigen.

Authors:  Chom-Kyu Chong; Wooseog Jeong; Hak-Yong Kim; Dong-Jun An; Hye-Young Jeoung; Jeong-Eun Ryu; A-Ra Ko; Yong-Joo Kim; Sung-Jong Hong; Zhaoshou Yang; Ho-Woo Nam
Journal:  Korean J Parasitol       Date:  2011-09-30       Impact factor: 1.341

9.  Results of the National External Quality Assessment for Toxoplasmosis Serological Testing in China.

Authors:  Kuo Zhang; Lunan Wang; Guigao Lin; Yu Sun; Rui Zhang; Jiehong Xie; Jinming Li
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

10.  Isothermal PCR for Feasible Molecular Diagnosis of Primary Toxoplasmosis in Women Recently Experienced Spontaneous Abortion.

Authors:  Amany A Abd El Aal; Reham K Nahnoush; Marwa A Elmallawany; Walid S El-Sherbiny; Mohamed S Badr; Ghada M Nasr
Journal:  Open Access Maced J Med Sci       Date:  2018-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.